Back to search

Immutrin Ltd

12217886

active
Private Limited Company
england wales
Companies House
0 outstanding charges
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

CAMBRIDGE INNOVATION CAPITAL, CAMBRIDGE, CB1 2JD
Incorporated 20/09/2019

Compliance

Last accounts

31/08/2025

total exemption full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 19/09/2025

Due 03/10/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Michael Leith Anstey

director · Since 03/12/2019

VENTURE CAPITAL INVESTOR

BRITISH · UNITED KINGDOM · Age 45

Also on 3 other boards

Dr Mihriban Tuna

director · Since 06/02/2024

SCIENTIST

BRITISH · UNITED KINGDOM · Age 52

Dr Sef Kurstjens

director · Since 01/02/2025

DIRECTOR

AMERICAN · UNITED STATES · Age 62

Mr Alexander Jack Kellow Sinclair-Wilson

director · Since 02/02/2026

BRITISH · UNITED KINGDOM · Age 39

Mr Nihal Sinha

director · Since 02/02/2026

BRITISH · UNITED KINGDOM · Age 41

Mr James Newman Topper

director · Since 02/02/2026

AMERICAN · UNITED STATES · Age 64

Persons with Significant Control

Cambridge Innovation Capital Limited

25–50% shares
25–50% votes

22, Station Road, Cambridge, CB1 2JD

Reg: 08243718 · Companies House · Corporate

Notified 31/03/2022

Former PSCs

Daniel Christ

Ceased 03/12/2019

Professor Mark Brian Pepys

Ceased 31/03/2022

Sir Gregory Paul Winter

Ceased 03/12/2019

Charges0 outstanding

A registered charge
fully satisfied

Hsbc Innovation Banking

Created 14/05/2026Registered 15/05/2026Satisfied 04/06/2026

CompanyRankvs 768+ SIC 72110 peers
68

Financial strength50th percentile among SIC peers · 13/25
Employees87th percentile among SIC peers · 13/15
LiquidityCurrent ratio 4.26× · 20/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength13/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/08/2025

Net Worth

£236

Balance sheet strength

Cash

£551k

Cash in the bank

Net Current Assets

£589k

Working capital

Current Assets

£770k

Current Liabilities

£181k

Fixed Assets

£11k

Debtors

£219k

Profit After Tax

-£1.0M

6avg. employees

Balance Sheet

Assets less current liabilities£601k
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20254.26
2024-£1.1M
202242.83
202135.23
202024.34

Derived from filed accounts. Not audited figures.